Home › Compare › NVTA vs RYLD

NVTA vs RYLD: Dividend Comparison 2026

NVTA yields 10526.32% · RYLD yields 12.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NVTA wins by $91421458538285344.00M in total portfolio value
10 years
NVTA
NVTA
● Live price
10526.32%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$91421458538285344.00M
Annual income
$89,744,322,218,307,970,000,000.00
Full NVTA calculator →
RYLD
RYLD
● Live price
12.14%
Share price
$14.95
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.5K
Annual income
$2,587.35
Full RYLD calculator →

Portfolio growth — NVTA vs RYLD

📍 NVTA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNVTARYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NVTA + RYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NVTA pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVTA
Annual income on $10K today (after 15% tax)
$894,736.84/yr
After 10yr DRIP, annual income (after tax)
$76,282,673,885,561,770,000,000.00/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,031.60/yr
After 10yr DRIP, annual income (after tax)
$2,199.25/yr
At 15% tax rate, NVTA beats the other by $76,282,673,885,561,770,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVTA + RYLD for your $10,000?

NVTA: 50%RYLD: 50%
100% RYLD50/50100% NVTA
Portfolio after 10yr
$45710729269142672.00M
Annual income
$44,872,161,109,153,986,000,000.00/yr
Blended yield
98.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RYLD right now

NVTA
Analyst Ratings
4
Buy
6
Hold
5
Sell
Consensus: Hold
Price Target
$9.75
+51215.8% upside vs current
Range: $2.25 — $17.00
Altman Z
-23.1
Piotroski
4/9
RYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVTA buys
0
RYLD buys
0
No recent congressional trades found for NVTA or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNVTARYLD
Forward yield10526.32% ✓12.14%
Annual dividend / share$2.00 ✓$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$91421458538285344.00M ✓$44.5K
Annual income after 10y$89,744,322,218,307,970,000,000.00 ✓$2,587.35
Total dividends collected$91309952364754128.00M ✓$18.8K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: NVTA vs RYLD ($10,000, DRIP)

YearNVTA PortfolioNVTA Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$1,063,332$1,052,631.58$11,914$1,213.65+$1.05M → NVTA
2$105,744,905$104,607,140.08$14,099$1,351.30+$105.73M → NVTA
3$9,835,430,757$9,722,283,708.79$16,580$1,494.55+$9835.41M → NVTA
4$855,644,041,989$845,120,131,078.84$19,384$1,642.61+$855644.02M → NVTA
5$69,627,827,846,009$68,712,288,721,080.95$22,535$1,794.70+$69627827.82M → NVTA
6$5,300,152,192,813,391$5,225,650,417,018,161.00$26,063$1,950.00+$5300152192.79M → NVTA
7$377,430,657,448,967,200$371,759,494,602,656,830.00$29,995$2,107.69+$377430657448.94M → NVTA
8$25,145,413,383,015,215,000$24,741,562,579,544,820,000.00$34,361$2,266.99+$25145413383015.18M → NVTA
9$1,567,417,121,474,185,500,000$1,540,511,529,154,359,300,000.00$39,194$2,427.12+$1567417121474185.50M → NVTA
10$91,421,458,538,285,340,000,000$89,744,322,218,307,970,000,000.00$44,525$2,587.35+$91421458538285344.00M → NVTA

NVTA vs RYLD: Complete Analysis 2026

NVTA — Stock

Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Full NVTA Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this NVTA vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVTA vs SCHDNVTA vs JEPINVTA vs ONVTA vs KONVTA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.